Skip to main content

Table 1 Patient-related and joint-related characteristics of study material. VAS Visual Analogue Scale, CRP C-reactive protein, ESR erythrocyte sedimentation date, DAS Disease activity score, CDAI clinical disease activity index, PET/CT positron emission computed tomography, SD standard deviation

From: Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission

Variable

Patient (N = 63) Mean ± SD or Number (%)

Joints (N = 1764)

Number (%)

Anamnestic disease activity

 Patient global assessment - VAS (mm)

43.0 ± 30.6

 

 Physician global assessment - VAS (mm)

20.1 ± 26.2

 

 Health Quality Questionnaire

13.3 ± 13.0

 

Blood analysis

 CRP (mg/L)

3.3 ± 4.4

 

 ESR (mm/h)

11.3 ± 12.1

 

Clinical examination

 Number of tender joint

5.9 ± 8.2

373 (21.1)

 Number of swollen joint

3.8 ± 4.6

242 (13.7)

 Number of tender or swollen joint

7.7 ± 8.0

486 (27.6)

 Number of tender and swollen joint

2.1 ± 4.3

129 (7.3)

DAS28-CRP

3.4 ± 1.5

 

 Remission (< 2.6)

22 (34.9)

 

 Low /moderate activity (2.6–5.1)

31 (49.2)

 

 Severe activity (> 5.1)

10 (15.9)

 

CDAI

16.1 ± 15.2

 

 Remission (≤2.8)

11 (17.5)

 

 Low /moderate activity (2.9–22)

37 (58.7)

 

 Severe activity (> 22)

15 (23.8)

 

Ultrasounds

 Synovitis (positive joints)

2.4 ± 3.2

152 (8.6)

 Cumulative synovial thickness (mm)

8.3 ± 13.1

 

PET/CT

 Positive joints

5.7 ± 7.9

361 (20.5)

 Cumulative standard uptake value

12.8 ± 19.1